In order to identify such interactions and potential drug targets, we extended our study to cell surface receptor molecules which are sialylated and may respond differently due to altered sialylation
Retrieved from Gikonyo, D., Gikonyo, A., Luvayo, D., & Ponoth, P
SongXJiaHJiangYWangLZhangYMuYet alAnti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 diabetes Mellitus: a meta-analysis
These changes happen gradually, often over months, and many users do not notice them until the damage is significant
For long-term, sustainable weight reduction, ongoing treatment and healthy lifestyle changessupported by our expert medical teamdeliver the most profound benefits
PMID 18348191